mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.008 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.008 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.008 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.009 |
mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.01 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.01 |